Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.82
- Piotroski Score 3.00
- Grade Hold
- Symbol (QTRX)
- Company Quanterix Corporation
- Price $11.18
- Changes Percentage (-2.27%)
- Change -$0.26
- Day Low $11.03
- Day High $11.65
- Year High $29.70
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/12/2024
- Fiscal Year End N/A
- Average Stock Price Target $25.00
- High Stock Price Target $32.00
- Low Stock Price Target $13.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.96
- Trailing P/E Ratio -17.71
- Forward P/E Ratio -17.71
- P/E Growth -17.71
- Net Income $-32,334,000
Income Statement
Quarterly
Annual
Latest News of QTRX
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Quanterix Corp (QTRX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Instrument ...
Sales from the Accelerator Lab in the quarter were mostly from recurring customers, with a 36% growth. The strategy of combining consumables and services resulted in 80% recurring revenues. Diagnostic...
By Yahoo! Finance | 5 days ago
